Atara Biotherapeutics
Stock Forecast, Prediction & Price Target
Atara Biotherapeutics Financial Estimates
Atara Biotherapeutics Revenue Estimates
Atara Biotherapeutics EBITDA Estimates
Atara Biotherapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $20.34M N/A | $63.57M 212.55% | $8.57M -86.51% | Avg: $69.38M Low: $69.38M High: $69.38M avg. 709.28% | Avg: $94.26M Low: $94.26M High: $94.26M avg. 35.86% | Avg: $224.16M Low: $224.16M High: $224.16M avg. 137.80% | Avg: $150M Low: $150M High: $150M avg. -33.08% |
Net Income
% change YoY
| $-340.14M N/A | $-228.30M 32.88% | $-276.12M -20.94% | Avg: $-61.41M Low: $-61.41M High: $-61.41M avg. 77.75% | Avg: $-72.07M Low: $-72.07M High: $-72.07M avg. -17.36% | Avg: $3.17M Low: $3.17M High: $3.17M avg. 104.40% | Avg: $-15.88M Low: $-15.88M High: $-15.88M avg. -600.00% |
EBITDA
% change YoY
| $-340.46M N/A | $-330.75M 2.85% | $-265.99M 19.57% | Avg: $-13.87M Low: $-13.87M High: $-13.87M avg. 94.78% | Avg: $-18.85M Low: $-18.85M High: $-18.85M avg. -35.86% | Avg: $-44.83M Low: $-44.83M High: $-44.83M avg. -137.80% | Avg: $-29.99M Low: $-29.99M High: $-29.99M avg. 33.08% |
EPS
% change YoY
| -$3.63 N/A | -$2.24 38.29% | -$65.18 -2809.82% | Avg: -$14.5 Low: -$14.5 High: -$14.5 avg. 77.75% | Avg: -$17.01 Low: -$17.01 High: -$17.01 avg. -17.36% | Avg: $0.75 Low: $0.75 High: $0.75 avg. 104.40% | Avg: -$3.75 Low: -$3.75 High: -$3.75 avg. -600% |
Operating Expenses
% change YoY
| $360.80M N/A | $344.08M -4.63% | $275.69M -19.87% | Avg: $177.72M Low: $177.72M High: $177.72M avg. -35.53% | Avg: $241.46M Low: $241.46M High: $241.46M avg. 35.86% | Avg: $574.22M Low: $574.22M High: $574.22M avg. 137.80% | Avg: $384.24M Low: $384.24M High: $384.24M avg. -33.08% |
FAQ
What is Atara Biotherapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -108.79% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -61.41M, average is -61.41M and high is -61.41M.
What is Atara Biotherapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 212.46% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $69.38M, average is $69.38M and high is $69.38M.
What is Atara Biotherapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -108.79% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$14.5, average is -$14.5 and high is $-14.49.